Implant Failures

Dental implants are a predictable and effective modality for replacing missing teeth, with high long-term survival rates. However, implant failure can occur due to biologic, mechanical, or patient-related factors. Risk factors, such as smoking, uncontrolled-systemic diseases (e.g. diabetes), certain medications, and a history of periodontitis, must be screened and identified during the treatment planning phase. Although absolute contraindications are rare, thorough patient evaluation and coordination with the patient’s physician are critical for optimal outcomes.

Key points

  • Patient risks factors for dental implants should be carefully assessed during the treatment planning phase, and not later in the course.

  • Smoking is a significant factor causing implant failure.

  • Systemic factors including diabetes, drugs/medications, radiation, and autoimmune conditions may pose a risk for dental implants.

  • Existing and previous history of periodontitis may adversely affect implant survival.

Abbreviations

BMD bone mineral density
IL Interleukin

Introduction

In modern dentistry, dental implants have become a widely accepted method for restoring edentulous areas. Dental implants are now considered a viable alternative to conventional therapies, for replacing partially or fully edentulous arches. In implantology, the emphasis is predominantly on the technical precision of implant placement and strict adherence to established protocols. However, relatively little focus is placed on identifying and managing risk factors associated with implant failure. Many a time, the diagnostic process in implant dentistry often dedicates insufficient time to the comprehensive evaluation and mitigation of these risk factors. Therefore, it is crucial for dental implant clinicians to develop an in-depth understanding of the various factors that contribute to implant failure, in order to enhance treatment outcomes, and ensure prognosis and long-term success. Implant failure factors relating to the restorative and surgical components are addressed elsewhere in this special edition. In this article, we discuss definition, prevalence, classification, and the systemic factors that influence implant success and failure.

Definition of implant failure

There is no definitive universally acceptable definition for implant failure. This is primarily by the virtue of the fact that numerous variables may define the failure differently. For example, the criteria for labeling an implant as “failed” may vary considerably across the dental literature. It must be noted, that although the clinician may consider the implant as “successful”, a patient believing it has failed due to whatever the patient factors are, may essentially end up as a “case failure”. In this article, we have looked primarily at the biologic basis for implant failures. Another philosophic question is the potential difference between implant “failure” as opposed to the “sub-optimal success” of the implant. Another factor to consider is the level of residual healthy bone that supports the implant, as a factor of “success” or “failure”. For example, if 50% of the supporting bone is eroded off, but the implant is otherwise stable, can this be labeled as “success” or “failure” or “sub-optimal implant survival”.

The definition of implant failure appears to be widely varied in literature, with no apparent consensus between and amongst various professional organizations and academies. Implant failure is loosely defined as the instance where a decision for removal of a dental implant has been made, due to clinical signs or symptoms that indicate the inability to maintain its function and stability. In this definition, “failure” specifically refers to the loss of the implant fixture, rather than subjective outcomes, such as aesthetics and other factors. An implant is considered failed when biologic or mechanical complications necessitate its removal, irrespective of the underlying cause. ,,,

Implant success

An implant is considered successful when it remains in place with healthy surrounding hard and soft tissues, demonstrating proper osseointegration and functional stability without any signs of pathology. However, the question in a clinician’s mind becomes this: The implant appears well-integrated and “stable” but has gone through 50% bone loss: Is this a successful implant? How about if we extrapolate this to a case with 75% bone loss, but still satisfies the criteria for “stability”? When considering the actual failure of implants, it appears that there is a spectrum starting with the initial implant “success” to implant “survival” through implant “failure”. For a dental clinician, success is determined by achieving the patient’s desired outcome without any associated complications. Any need for additional treatment post-procedure, such as patient dissatisfaction with prosthetic aesthetics despite clinical success, qualifies as a complication due to the necessity of further intervention. Under this definition, success rates would be significantly lower than those based solely on implant integration. An implant is considered to have survived when it remains in place, but exhibits compromised surrounding hard or soft tissues, such as bone loss, peri-implantitis, or other complications, while still maintaining functionality without requiring removal.

Prevalence of implant failure

Dental implants have a reported 10 y survival rate of approximately 95%. The reported prevalence of early and late implant failure (at the implant level) varies between 0.5% to 5% and 0.5% to 8%, respectively. Variations in prevalence may be influenced by implant design, surgical protocol, and sample characteristics. Additionally, the length of the follow-up period may contribute to differences in late failure rates.

Basis of classification of implant failure

Type of Failure Based on Time Elapsed from Implant Placement

Early implant failure is defined as the failure/lack of osseointegration prior to functional loading of dental implant. It is typically observed within the initial weeks to months following implant placement. Early failures represent a failure of the initial healing phase and are considered a biologically driven phenomenon rather than a mechanical or functional complication. , Late implant failure refers to the loss of an Osseo-integrated implant, typically occurring during or after the restorative phase following the application of occlusal loading. Unlike early failures, which are solely biologic, late failures can result from either biologic or mechanical complications. , The time interval between the initial diagnosis of implant failure and its eventual removal is generally longer in late failures compared to early failures, and they are often associated with significant peri-implant bone loss. Since late failures occur after the final prosthetic restoration has been placed, they pose greater challenges in terms of retreatment, cost implications, and patient dissatisfaction. , A summary of classification of implant failure based on time factor is given in Table 1 .

Table 1

Classification of implant failures based on time elapsed from placement

Type of Failure Timing
Early failure (before functional loading) Weeks to months after placement
Late failure (after functional loading) Months to years’ post-placement
Very late failure (few years after functional loading) Years after successful osseointegration

Classification of Implant Failure Based on Phases of Implant Treatment

Dental implant failure can be classified according to the different phases of treatment, ranging from pre-operative planning to long-term prosthetic function. Each phase presents unique challenges and risk factors that can contribute to implant failure. A summary of this classification is given in Table 2 .

Table 2

Classification of implant failure based on phases of implant treatment

Treatment Phase Timing of Failure
Planning Early failure (prior to surgery)
Surgical Early failure (during or shortly after surgery)
Healing and osseointegration Early failure (before functional loading—weeks to months after surgery)
Restorative Late failure
Functional Late failure

Etiology of Implant Failures: Patient Factors

Numerous factors affect the success and survival of implants, and many of these are patient-related. These include systemic, anatomic, parafunctional, and other factors. A summary of this is included in Table 3 .

Table 3

Patient factors in implant failure

Patient Factor Entities
Systemic factors
  • 1.

    Age

  • 2.

    Smoking

  • 3.

    E-cigarette and cannabis

  • 4.

    Diabetes mellitus

  • 5.

    Osteoporosis

  • 6.

    Anti-resorptive medications

  • 7.

    Glucocorticoid

  • 8.

    Anti-depressant

  • 9.

    Proton pump inhibitors

  • 10.

    Radiation therapy (head and neck)

  • 11.

    Prophylactic antibiotic

  • 12.

    Immunosuppressants

  • 13.

    Nonsteroidal

  • 14.

    Anti-inflammatory drugs

  • 15.

    Vitamin D

  • 16.

    Thyroid hormones

  • 17.

    Cardiovascular diseases

  • 18.

    Anti-hypertensive medications

  • 19.

    Movement disorders

  • 20.

    Genetic disorders

  • 21.

    Penicillin allergy

  • 22.

    Inflammatory bowel diseases

  • 23.

    Fibrous dysplasia

  • 24.

    Cement-osseous dysplasia

  • 25.

    Osteogenesis imperfecta

  • 26.

    Epidermolysis bullosa

  • 27.

    Oral lichen planus

  • 28.

    Sjogren syndrome

  • 29.

    Systemic sclerosis

  • 30.

    Rheumatoid arthritis

  • 31.

    Papillon-Lefévre Syndrome

  • 32.

    Psychiatric disorders

Local factors
  • 1.

    Bone quality (maxillary vs mandibular)

  • 2.

    Location of implant (maxillary vs mandibular; anterior vs posterior)

  • 3.

    Raw (immediate) vs healed (delayed) socket

  • 4.

    Health of oral tissues

Parafunction Bruxism
Other factors
  • 1.

    Allergic reaction

  • 2.

    Periodontal disease

  • 3.

    History of orthodontic treatment

  • 4.

    Oral hygiene

  • 5.

    Post-implant neuropathy and pain

Age

The relationship between age and early implant failure remains controversial. Earlier implant literature reported that older age was significantly associated with higher implant failure rate. PMID: 16161741 More recent studies reported no significant correlation between the age and early implant failure, except older adults in their 80s and beyond may have a subtle propensity for a higher early implant failure. ,, A recent retrospective study demonstrated that younger patients exhibited a higher incidence of early dental implant failure, with the risk of failure decreasing by approximately 13% to 15% for every additional decade of age. Age alone is not a determinant of early implant failure—rather, patient-specific factors, such as local and systemic factors, and peri-implant care, play a more critical role. Patients ≥80 y may have a slightly higher risk of failure, necessitating careful treatment/surgical planning, prosthetic considerations, and long-term maintenance strategies.

Smoking

The detrimental impact of smoking on systemic and oral health is well-documented. It adversely affects oral tissues, compromising both soft and hard tissue integrity. ,, Smoking is recognized as a key risk factor for impaired wound healing, dry socket, implant failure, and marginal bone loss around both natural teeth and dental implants. In the context of dental implants, a significant association has been established between smoking and an increased risk of implant failure, , particularly in the maxilla. This site-specific susceptibility may be attributed to several anatomic and physiologic factors, including reduced cortical bone thickness, compromised bone quality, greater direct exposure of the palatal tissues to tobacco smoke, and the absence of protective mechanisms, such as tongue coverage, which may exacerbate the deleterious effects of smoking. Evidence suggests that smokers exhibit altered-bone structure and composition compared to non-smokers. , Cigarette smoking has been linked to a reduction in bone mineral density (BMD) in a dose-dependent and duration-dependent manner. Existing literature supports evidence that smoking adversely affects the prognosis of dental implants in a dose-dependent manner. A recent meta-analysis indicates that smoking significantly increases the risk of early implant failure by 1.5-fold to 2.5-fold. However, tobacco use alone may not be a definitive risk factor for early implant failure. Smoking cessation for at least 8 d before and continuing through 60 d after implant placement has been shown to enhance implant survival rates in smokers. , Comprehensive pre-operative assessment should include evaluation of smoking history, and dental professionals must integrate structured-counseling and cessation strategies into the treatment plan. Such proactive interventions can significantly enhance implant outcomes, particularly in high-risk individuals, and should be considered standard practice in implantology.

E-cigarette and cannabis

Emerging evidence indicates that e-cigarette use has an adverse effect on the clinical, radiographic, and immunologic outcomes associated with dental implants. Similar to conventional cigarette smoking, e-cigarettes may compromise the healing process and overall outcomes of implant therapy. ,, Cannabis use has been linked to impaired-gingival healing due to the presence of nicotine and the inhibitory effects of cannabidiol on cell proliferation, as well as reduced levels of interleukin-8 (IL-8)—a cytokine essential for wound repair. Additionally, heavy cannabis users exhibit decreased BMD, lower body mass index, higher fracture rates, and reduced-serum vitamin D levels. Together, these effects suggest that chronic cannabis consumption may negatively impact both soft tissue healing and overall bone health, potentially compromising implant treatment outcomes.

Systemic factors affecting implant failure: possible mechanism and management

A number of systemic factors have been proposed and shown to robustly influence the success and survival of dental implants. It must be noted that some of the corresponding literature in this regard is still emerging. A summary of these factors is included in Table 4 . A few of these factors are exemplified in Fig. 1 A–C .

Table 4

Systemic factors affecting implant failure: possible mechanism and management

Systemic Factor Potential/Shown Effect on Dental Implant Clinical Pearls in Management
DM
  • Higher incidence of dental implant failure in diabetes mellitus. ,

  • No impact when blood glucose levels are well-controlled and maintained.

  • Optimal maintenance of HbA1c ,

Osteoporosis
  • Systemic osteoporosis does not exhibit higher dental implant failure; may have increased peri-implant bone loss. ,

  • Minimize peri-implant bone loss.

Anti-resorptive medications.
Bis- phosphonate (BP)
  • Increased risk of dental implant failure, potentially due to their negative impact on osseointegration. ,

  • Intravenous (IV) administration increases skeletal drug deposition and implant failure risk.

  • IV or long-term oral bisphosphonate therapy increases the risk of medication-related osteonecrosis of the jaw (MRONJ), potentially compromising dental implant success.

  • Obtain a detailed medical history, including the type of medication, dosage, route of administration (oral vs IV), and duration of use.

\Glucocorticoids
  • Prolonged use may impair osseointegration. ,

  • Potential for suboptimal dental implant outcomes. ,

  • Limited evidence ,

  • A thorough risk assessment

Anti-depressants (SSRI)
  • Increased risk of dental implant failure. ,,

  • Negative effects on bone metabolism. ,

  • Impair osseointegration. ,

  • Specific drug and duration of exposure may be factors.

  • Careful risk assessment

  • Informed consent

Proton-pump inhibitors (PPI)
  • PPIs can reduce absorption of calcium, vitamin B12, magnesium, and iron.

  • Linked to higher implant failures. ,

  • No link between PPIs and implant failure or peri-implantitis after controlling other risk factors.

  • Evaluation of PPI use

  • Risk assessment

  • Discretion of clinicians

Radiation therapy
  • Higher failure rate in irradiated bone. ,

  • Irradiated grafted bone has a higher failure rate than irradiated native bone. ,

  • Safe in patients exposed to, up to approximately 35 Gy radiation. ,

  • Lead shielding of implant sites helps in achieving and maintaining osseointegration.

Prophylactic Antibiotic
  • Offers limited benefit and is generally not recommended.

  • Reserved for specific clinical indications rather than used universally.

Immuno-Suppressants (CsA)
  • Cyclosporine A may negatively affect peri-implant bone health, impacting implant prognosis. ,

  • The use of this agent should be carefully evaluated both prior to and during implant therapy.

Nonsteroidal Anti-inflammatory Drugs (NSAIDS)
  • Potential negative effect on implant osseointegration. ,

  • Alternative pain management strategies should be considered.

Vitamin- D
  • Potential role in maintaining bone health, which may indirectly support implant success.

  • The direct impact on osseointegration remains inconclusive.

Thyroid Hormones
  • Implant survival is comparable to that in healthy individual. ,

  • Wait at least 2 w after radioiodine therapy before implant placement.

Cardiovascular Diseases (CVDs)
  • No definitive correlation between CVDs and increased implant failure. ,

  • Implant surgery is generally safe without stopping single antiplatelet agents.

Movement disorder
  • Oral hygiene-related, increased risk of early implant failure.

  • Meticulous oral hygiene maintenance.

  • The prosthesis design should ensure easy maintenance.

Genetic disorder
  • Down syndrome (DS) patients exhibit higher failure rates. ,

  • Implant failure is significantly lower in DS patients without periodontitis compared to those with it.

Penicillin allergy
  • Linked with early implant failure.

  • Unclear whether penicillin allergy, clindamycin use, or their combination contributes to implant failure.

Inflammatory bowel diseases
  • Limited evidence suggests that malnutrition, poor bone quality, and other associated risk factors may contribute to dental implant failure.

  • Clinicians should exercise caution when planning invasive dental procedures in patients receiving monoclonal antibodies.

  • Bevacizumab, sunitinib, and denosumab have been directly associated with MRONJ.

Anti-hypertensive medications
  • Positive impact on bone metabolism. 39,244,244 ,

  • Potential improvement in survival rates. ,

  • Drug-induced gingival enlargement is rare in edentulous areas but may occur after implant placement.

  • Pre-operative counseling should address risks of drug-induced gingival enlargement.

Fibrous Dysplasia (FD)
  • Limited evidence to draw definitive conclusions.

  • Failed implants in FD may increase the risk of osteomyelitis.

  • Placement should be delayed until FD lesion stabilizes.

  • Cone-beam computed tomography.

  • In young patients, wait until skeletal maturity to avoid implant submergence and prosthetic revision.

Cemento- osseous dysplasia (COD)
  • Limited evidence to draw definitive conclusions. ,

  • COD patients are not ideal implant candidates; the condition is not an absolute contraindication.

  • Clinical and radiographic follow-up.

  • Infection control and minimal invasive technique.

Osteogenesis imperfecta (OI)
  • Significant challenges due to compromised skeletal integrity and reduced bone mineral density (BMD).

  • Patients on antiresorptive therapy require caution due to the risk of MRONJ.

Epidermolysis bullosa
  • Clinical outcomes are comparable to healthy individuals. ,

  • Restoration of masticatory function is critical, as inadequately chewed food may cause mucosal trauma.

  • Dental procedures should be minimally invasive and performed with extreme caution to avoid soft tissue injury.

Oral lichen planus
  • Implant survival is comparable to that in healthy individuals. ,

  • Dental implant insertion should be deferred until disease remission is achieved to optimize outcomes. ,

Sjogren syndrome (SS)
  • Limited evidence suggests dental implants in SS patients may show reduced success rates but overall clinical performance remains comparable to healthy individual. ,

  • Address the dry mouth.

  • Meticulous oral hygiene with increased recall frequency.

  • Mitigate possible effects of immunosuppressants.

Systemic sclerosis (SSc)
  • Limited evidence suggests no significant impact on dental implant survival rates. ,

  • Manual dexterity and limited mouth opening should be considered during both pre-operative assessment and postoperative care in implant treatment.

Rheumatoid arthritis (RA)
  • Relative contraindication.

  • Informed consent.

  • Mitigate possible effects of immunosuppressants.

Papillon-Lefevre syndrome
  • Lower success rates compared to healthy individuals. ,,

  • No absolute contraindication. ,

  • Optimal oral hygiene and rigorous maintenance protocols are critical. ,

Psychiatric disorders
  • Limited evidence.

  • Not a contraindication. ,

  • Antipsychotic medications, cognitive impairment, and reduced motivation negatively affect oral hygiene maintenance. ,

  • Caution: SSRI/SNRI

Only gold members can continue reading. Log In or Register to continue

Stay updated, free dental videos. Join our Telegram channel

Jul 12, 2026 | Posted by in Oral and Maxillofacial Surgery | Comments Off on Implant Failures

VIDEdental - Online dental courses

Get VIDEdental app for watching clinical videos